Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Oct 21, 2013

Claritas Partners with Life Tech, Lockheed to Sequence Military Veteran Exomes

  • As part of a project that reportedly is one of the largest sequencing initiatives ever undertaken in the U.S., the Department of Veterans Affairs awarded Claritas Genomics a $9 million contract toward the exome sequencing of veteran samples including those from the Million Veteran Program (MVP) over the next 12 months.

    For this project, Claritas Genomics, a genetic testing company spun out of Boston Children's Hospital earlier this year that primarily focuses on pediatric medicine, is receiving support from Life Technologies and its Ion Proton™ sequencing technology; Alvarez and Associates, which is providing technical support; and Lockheed Martin, which will be applying data security knowledge to help manage all the data that will be generated during the sequencing process.

    MVP, a research program launched in 2011, is combining genetic, health, lifestyle, and military-exposure data collected from questionnaires, medical records, and genetic analyses all into a single database. MVP has more than 210,000 enrollees to date, and it is hoped that up to a million veterans in the VA study will enroll over the next five to six years. 

    "As a U.S. military veteran, I am proud of the fact that my company is able to serve those individuals who were/are willing to sacrifice all in service to our country," said Everett Alvarez, Jr., CEO at Alvarez & Associates, in a statement. "I feel that this effort will greatly improve our ability to understand and better assist those veterans in need as well as the future generations of veterans."



Related content

Be sure to take the GEN Poll

Cancer vs. Zika: What Worries You Most?

While Zika continues to garner a lot of news coverage, a Mayo Clinic survey reveals that Americans believe the country’s most significant healthcare challenge is cancer. Compared to other diseases, does the possibility of developing cancer worry you the most?

More »